Literature DB >> 22249557

Association between angiotensin-converting enzyme gene polymorphism and diabetic retinopathy in the Chinese population.

Yan Lu1, Yirui Ge, Qinrui Hu, Yuhua Shi, Chunyan Xue, Yao Shi, Suihua Chen, Zhenping Huang.   

Abstract

OBJECTIVE: The angiotensin-converting enzyme (ACE) gene has been implicated in the development of diabetic retinopathy (DR). However, the results have been conflicting. In this study, we performed a meta-analysis to assess the association of insertion/deletion (I/D) polymorphism in the ACE gene with DR in the Chinese population.
METHODS: Published literature from PubMed, CNKI, CBM and Wanfang Data were retrieved. Pooled odds ratio (OR) with 95% confidence interval (CI) was calculated using fixed- or random-effects model.
RESULTS: Seventeen studies (1039 cases and 1185 controls) for I/D polymorphism in the ACE gene were identified. The results suggested that I/D polymorphism D allele might increase the risk of DR (DD vs. II: OR = 1.73, 95% CI 1.19-2.51; DD+ID vs. II: OR = 1.41, 95% CI 1.16-1.72; DD vs. ID+II: OR = 1.55, 95% CI 1.13-2.12). Subgroup analyses based on the type of DR showed that the effect size was statistically significant for proliferative DR (PDR) (DD vs. II: OR = 2.67, 95% CI 1.53-4.64; DD+ID vs. II: OR = 1.86, 95% CI 1.18-2.93; DD vs. ID+II: OR = 2.22, 95% CI 1.38-3.55), but not for background DR (BDR) (DD vs. II: OR = 1.38, 95% CI 0.85-2.25; DD+ID vs. II: OR = 1.40, 95% CI 0.98-2.02; DD vs. ID+II: OR = 1.15, 95% CI 0.74-1.79).
CONCLUSION: The results indicated that I/D polymorphism in the ACE gene was associated with PDR, but not with BDR in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249557     DOI: 10.1177/1470320311432187

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  8 in total

1.  Implications of ACE (I/D) Gene Variants to the Genetic Susceptibility of Coronary Artery Disease in Asian Indians.

Authors:  G K Bhatti; J S Bhatti; R Vijayvergiya; B Singh
Journal:  Indian J Clin Biochem       Date:  2016-07-13

2.  Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy.

Authors:  Saba Saleem; Aisha Azam; Sundus Ijaz Maqsood; Irfan Muslim; Shaheena Bashir; Nosheen Fazal; Moeen Riaz; Syeda Hafiza Benish Ali; Muhammad Khizar Niazi; Mazhar Ishaq; Nadia Khalida Waheed; Raheel Qamar; Maleeha Azam
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

3.  Genetics in diabetic retinopathy: current concepts and new insights.

Authors:  Olga Simó-Servat; Cristina Hernández; Rafael Simó
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

4.  Angiotensin-converting enzyme gene variants interact with the renin-angiotensin system pathway to confer risk and protection against type 2 diabetic retinopathy.

Authors:  Balneek Singh Cheema; Harbir Singh Kohli; Rajni Sharma; Viral N Shah; Anil Bhansali; Madhu Khullar
Journal:  J Diabetes Investig       Date:  2013-01-29       Impact factor: 4.232

Review 5.  A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy.

Authors:  Zohreh Rahimi; Mahmoudreza Moradi; Hamid Nasri
Journal:  J Res Med Sci       Date:  2014-11       Impact factor: 1.852

Review 6.  Candidate gene studies of diabetic retinopathy in human.

Authors:  Petra Priščáková; Gabriel Minárik; Vanda Repiská
Journal:  Mol Biol Rep       Date:  2016-10-11       Impact factor: 2.316

7.  Association between the Angiotensin-Converting Enzyme (ACE) Genetic Polymorphism and Diabetic Retinopathy-A Meta-Analysis Comprising 10,168 Subjects.

Authors:  Shasha Luo; Chao Shi; Furu Wang; Zhifeng Wu
Journal:  Int J Environ Res Public Health       Date:  2016-11-15       Impact factor: 3.390

Review 8.  Candidate genes for proliferative diabetic retinopathy.

Authors:  Daniel Petrovič
Journal:  Biomed Res Int       Date:  2013-08-27       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.